| Literature DB >> 31239732 |
Chen Liang1,2, Wei Wei3, Xiuwen Liang1,2, Enjin De1,2, Beiwen Zheng4.
Abstract
Purpose: To investigate the demographic, epidemiological, clinical, and laboratory characteristics; treatment options; and outcome of human brucellosis with spine involvement at a major hospital in Hulunbuir, a brucellosis epidemic region of China. Patients and methods: A total of 842 patients with human brucellosis treated in the Department of Brucellosis, Hulunbuir People's Hospital from January 2011 to December 2016 were included and analyzed in this study. The results of 67 brucellar spondylodiscitis (BS) cases were compared with those that were negative for spine involvements.Entities:
Keywords: brucella melitensis; brucellosis; spine; spondylitis; treatment outcome
Year: 2019 PMID: 31239732 PMCID: PMC6559255 DOI: 10.2147/IDR.S202440
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Figure 1Age distribution and year distribution of 842 human brucellosis patients, Hulunbuir, China, 2011–2016. (A) Age distribution by sex. (B) Annual incidence of patients by sex. (C) Age distribution of patients with/without spinal brucellosis. (D) Annual incidence of patients with/without spinal brucellosis.
Comparison of demographical, clinical, and laboratory features of 842 cases of human brucellosis, Hulunbuir, China, 2011–2016
| Clinical characteristics | Patients with BS | Patients without BS | |
|---|---|---|---|
| Age (y) | 50.48±10.20 | 43.88±14.21 | 0.002 |
| Sex (male) | 43 (64.2) | 581 (75.0) | 0.053 |
| Risk factors for transmission | |||
| Direct contact with animals | 63 (94.0) | 751 (96.9) | 0.208 |
| Consumption of unpasteurized dairy products | 4 (6.0) | 24 (3.1) | 0.208 |
| Duration of symptoms | |||
| Acute | 51 (76.1) | 501 (64.6) | 0.058 |
| Subacute | 9 (13.4) | 75 (9.7) | 0.325 |
| Chronic | 5 (7.5) | 128 (16.5) | 0.051 |
| Relapse | 2 (3.0) | 71 (9.2) | 0.085 |
| Symptoms and clinical findings | |||
| Back pain | 67 (100) | 141 (18.2) | 0.000 |
| Fever | 57 (85.1) | 603 (77.8) | 0.166 |
| Sweats | 42 (62.7) | 538 (69.4) | 0.253 |
| Fatigue | 39 (58.2) | 512 (66.1) | 0.195 |
| Hepatomegaly | 3 (4.5) | 40 (5.2) | 0.807 |
| Splenomegaly | 12 (17.9) | 108 (14.1) | 0.372 |
| Laboratory data | |||
| WBC <4×10–9/L | 8 (11.9) | 69 (8.9) | 0.408 |
| PLT <100×10–9/L | 8 (11.9) | 62 (8) | 0.262 |
| ALT >40 U/L | 17 (25.4) | 147 (19) | 0.204 |
| AST >40 U/L | 18 (26.9) | 222 (28.6) | 0.757 |
| ESR >20 mm/hr | 42 (62.7) | 427 (55.1) | 0.230 |
| CRP >5 mg/L | 53 (79.1) | 542 (70.1) | 0.120 |
| SAT ≥1:100++ | 53 (79.1) | 534 (68.9) | 0.081 |
| Positive blood culture | 10 (14.9) | 67 (8.6) | 0.087 |
| | 7 (10.4) | 40 (5.2) | 0.126 |
| | 3 (4.5) | 27 (3.5) | 0.938 |
Notes: Data are expressed as patient number (%) or mean±standard deviation.
Abbreviations: BS, brucellar spondylodiscitis; WBC, white blood cell; PLT, platelet; ALT, alanine transaminase; AST, aspartate-aminotransferase; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; SAT, standard tube agglutination test.
MRI findings of 67 patients with brucellar spondylodiscitis
| MRI findings | n | % |
|---|---|---|
| Involved vertebrace | ||
| Lumbar | 56 | 81.2 |
| Thoracic | 4 | 6.0 |
| Thoracolumbar | 2 | 2.9 |
| Lumbosacra | 2 | 2.9 |
| Cervical | 3 | 4.3 |
| Abscess | ||
| Paravertebral abscess | 14 | 20.9 |
| Epidural abscess | 7 | 10.4 |